Business · 04/09/2012
FDA Clears Path for ALOXI (Palonosetron Hydrochloride) Capsules
The FDA has determined that ALOXI capsules, 0.5mg, were not withdrawn due to safety or effectiveness concerns, paving the way for potential approval of generic versions.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →